2026 · 2nd Quarter (Apr 1 - June 30)

BIOWOUND SOLUTIONS

Filed by THE MCMANUS GROUP.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 20, 2026
Income: $50,000.00
Expenses: Not reported
Registrant: THE MCMANUS GROUP
Client: BIOWOUND SOLUTIONS
Filing UUID: c94e9b0c-dd1b-461b-879f-d5a064affcb9
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to coverage of and reimbursement for Human Cell & Tissue products. Skin Substitute Access and Payment Reform Act of 2025 (H.R. 5768/S. 2561). H.R.6852 - To amend title XVIII of the Social Security Act to adjust payment for skin substitute products under the Medicare program. Issues related to skin substitute payment in 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F)

Literal federal measure citations: H.R. 5768, S. 2561, H.R.6852

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.